| HOME >> BIOLOGY >> TECHNOLOGY |
Due to related parties - non-trade 555,842 551,654
Current portion of long-term
liabilities 547,535 2,889
Total current liabilities 3,846,209 2,854,458
Long-term liabilities, less
current portion
Unsecured loans payable 1,676,604 1,574,350
Bank notes payable 13,420 17,988
Long-term convertible notes payable 1,519,439 2,058,625
Less:
discount relating to
long-term convertible notes
payable (609,325) (856,308)
Long-term convertible notes
payable - net 910,114 1,202,317
Total long-term liabilities 2,600,138 2,794,655
Minority interest in a subsidiary 91,382 110,838
Shareholders' equity (deficiency)
Common stock - $0.001 par value
Authorized 200,000,000 shares.
Issued and outstanding
88,788,245 and
81,519,676 shares at June 30, 2008
and December 31, 2007 88,788 81,520
Preferred stock - $0.001 par value
Authorized 20,000,000 shares,
none issued -- --
Additional paid-in capital 9,992,766 9,217,876
Stock-based compensation reserve (224,764) (307,053)
Deficit accumulated (12,391,738) (11,074,522)
Accumulated other comprehensive
income (38,833) (2,592)
Total shareholders'
equity (deficiency) (2,573,781) (2,084,771)
Total liabilities and
'/>"/>
| SOURCE Kiwa Bio-Tech Products Group Corporation Copyright©2008 PR Newswire. All rights reserved |